Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

• The company reported a negative return on equity of 102.72% for the most recent quarter, which indicates that the firm is generating negative returns relative to its shareholders' equity, a metric that can signal financial distress or significant accounting adjustments that may concern value-oriented investors.
• Insider selling activity has been notable, with CEO Jason Hollar and other executives selling a combined total of over 210,000 shares worth approximately $49.6 million over the last ninety days, which may suggest that company leadership is taking advantage of the recent stock price appreciation to reduce their personal exposure.
• Short interest in Cardinal Health, Inc. increased to 7,678,341 shares as of the latest record date, representing a 4.19% month-over-month increase, indicating that a portion of the market is betting against the stock's future performance despite recent positive earnings.
• The stock is trading at a price-to-earnings ratio of 35.44, which is relatively high compared to many traditional healthcare distributors, potentially leaving little room for error if future earnings growth does not meet the elevated expectations set by the recent guidance raise.
• Medical distribution faced pressure from modest commodity and petroleum-related headwinds during the recent quarter, suggesting that the company's cost structure remains vulnerable to external economic factors that could erode margins if these pressures persist or intensify.